Bluesky Facebook Reddit Email

Small test group shows ALS patients’ own cells may provide a safe pathway to slow or halt progression of the deadly degenerative disease

10.06.22 | Houston Methodist

Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Neurology

10.1212/NXI.0000000000200019

Experimental study

People

Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis

1-Nov-2022

Additional Media

John and Jill Lay talk about their family's ALS journey and the importance of research Credit: Houston Methodist
Darci Garcia and her family were part of the Houston Astros recognition of Lou Gehrig Day at Minute Maid Park on June 6, 2022, where this video premiered Credit: Houston Methodist

Keywords

Amyotrophic Lateral Sclerosis Disease Progression Regulatory T Cells

Article Information

Journal
Neurology
DOI
10.1212/NXI.0000000000200019
Method of Research
Experimental study
Subject of Research
People
Article Publication Date
2022-11-01
Article Title
Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis

Contact Information

Patti Muck
Houston Methodist
pamuck@houstonmethodist.org

How to Cite This Article

APA:
Houston Methodist. (2022, October 6). Small test group shows ALS patients’ own cells may provide a safe pathway to slow or halt progression of the deadly degenerative disease. Brightsurf News. https://www.brightsurf.com/news/LKN47VNL/small-test-group-shows-als-patients-own-cells-may-provide-a-safe-pathway-to-slow-or-halt-progression-of-the-deadly-degenerative-disease.html
MLA:
"Small test group shows ALS patients’ own cells may provide a safe pathway to slow or halt progression of the deadly degenerative disease." Brightsurf News, Oct. 6 2022, https://www.brightsurf.com/news/LKN47VNL/small-test-group-shows-als-patients-own-cells-may-provide-a-safe-pathway-to-slow-or-halt-progression-of-the-deadly-degenerative-disease.html.